The briefing
At the AIDS 2026 conference in Rio, researchers reported that CD4 mimetics may sensitize the immune system to HIV, potentially enhancing vaccine and antibody responses. The findings suggest broadly neutralizing antibodies alone may be insufficient for cure or long-term remission off antiretroviral therapy.
Original headline
A new class of drugs could sharpen the body’s immune response to HIV